Hemorrhagic transformation of ischemic brain tissue asymptomatic or symptomatic?

Stroke

Volumn 32, Issue 6, 2001, Pages 1330-1335

  Berger, Christian ^a   Fiorelli, Marco ^c   Steiner, Thorsten ^a   Schäbitz, Wolf Rüdiger ^a   Bozzao, Luigi ^c   Bluhmki, Erich ^d   Hacke, Werner ^a   Von Kummer, Rüdiger ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Hematoma; Hemorrhagic stroke; Stroke outcome; Thrombolysis

Indexed keywords

ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0034993089     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.6.1330     Document Type: Article

References (27)

1. Hemorrhagic cerebral infarction: A prospective study
2. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery
3. Hemorrhagic infarcts
4. Hemorrhagic transformation of brain infarct: Predictability in the first 5 hours from stroke onset and influence on clinical outcome
5. Streptokinase for acute ischemic stroke with relationship to time of administration
6. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke
7. Thrombolytic therapy with streptokinase in acute ischemic stroke
8. Tissue plasminogen activator for acute ischemic stroke
9. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
10. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey
11. Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness
12. Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
13. Local intra-arterial thrombolysis in acute ischemic stroke
14. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
15. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
16. Hemorrhagic transformation within 36 hours of a cerebral infarct: Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort
17. Thrombolytic agents in the treatment of stroke
18. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator
19. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
20. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction
21. Multicenter trial of hemodilution in ischemic stroke: Background and study protocol
22. Urgent therapy for stroke, part I: Pilot study of tissue plasminogen activator administered within 90 minutes
23. Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study
24. Ischaemic damage of brain microvessels: Inherent risks for thrombolytic treatment in stroke
25. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion
26. Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT?
27. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy